Related Blog Posts
Botox – The Temporary Wrinkle Solution
21 hours ago ago from Botox alternative
Botox is a huge splash in the areas of health and beauty market because of its ability to eliminate and reduce wrinkles. The overwhelming success of the BOTOX solution had fans lining up to get the beauty of their wrinkles. Botox treatments safe? After all, a protein toxin, botulinum toxin is produced by Clostridium botulinum. This is the first cousin of the deadly botulism bacteria. Botox is safe for use by opthamoligists More than a ...
Related contentCell Therapeutics (CTIC)
15 hours ago ago from GekkoWire
Cell Therapeutics (CTIC): Cell Therapeutics never disappoints. Cell announced some more positive efficacy data on their drug Pixantrone. For those that aren’t familiar with Cell’s lead product I’ll go through a brief overview. Pixantrone is currently under the FDA’s standard review process for refractory non-Hodgkin’s Lymphoma. The drug was designed to be a possible replacement for the standard cancer therapy doxorubicin. You see, cancer ...
Related contentYour Survival Guide To The Jungle Of Botox Treatments: Everything You Need To Know About Botox Inj | HEALTHY LIVING TIPS
9 hours ago ago from HEALTHY LIVING TIPS
12.08.2009 by admin in botox It derives from the bacteria Clostridium botulinum. In nature, large quantities of this exist. In these large doses, it can be harmful and it is this toxin that causes botulism. However, when small dilute quantities are used, as is done in therapeutic treatments, it is extremely safe and can be used under the skin to act as a muscle relaxant. How does it work? Botox is used to treat frown lines and ...
Related contentEpilepsy Drugs Don’t Cause Suicide Risk: Study
19 hours ago ago from Pharmalot
Still more controversy over this group of medications. A new study suggests that patients with bipolar disorder who take these anti-epileptic drugs do not have an increased risk of committing suicide, despite FDA warnings to the contrary ( back story here ). Bipolar patients treated with antiepileptics attempted suicide at the same rate as patients who received no medication or lithium. The rate of suicide attempts was higher before ...
Related contentFDA Keeps Close Eye on Meridia
4 hours ago ago from The Business Of Law
Call it food for thought. The U.S. Food and Drug Administration (FDA) is reviewing the preliminary findings of a new study of the weight loss drug Meridia. However, the agency recently released an early communication indicating that certain patients taking the drug may have a higher risk of heart attacks , strokes, and other cardiovascular problems. Consumer advocacy group Public Citizen last week asked the FDA to ban Meridia ...
Related contentRelated News
Many Dialysis Patients Get Wrong Blood Thinners for Angioplasty
20 hours ago ago from Forbes.com
TUESDAY, Dec. 8 (HealthDay News) -- More than one-fifth of patients on dialysis who undergo angioplasty are given blood thinners they should not be given, new research shows. As a result, these patients are subject to a higher rate of bleeding during their hospital stay and may even be at a higher risk of dying, according to a report in the Dec. 9 issue of the Journal of the American Medical Association . The drugs in question are ...
Related contentGAO: FDA yet to make safety changes post-Vioxx
3 hours ago ago from U.S. News
GAO: FDA yet to make safety changes post-Vioxx WASHINGTON (AP) -- The Food and Drug Administration still hasn't restructured its staff to better monitor drug safety, more than three years after experts recommended key changes in the wake of the Vioxx scandal. That's according to congressional investigators who found that the FDA has yet to follow through on changes suggested in 2006 to help the agency detect problems with drugs taken by ...
Related contentBHR Pharma Files Investigational New Drug Application, Receives Orphan Drug Designation, for Traumatic Brain Injury Treatment
19 hours ago ago from Good News Now
HERNDON, Va., Dec. 8 /PRNewswire/ -- BHR Pharma, LLC (BHR) announced today that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for its proprietary BHR-100 intravenous progesterone infusion product. In September of this year, the company made public plans to initiate a global, Phase 3, pivotal trial ( www.synapse-trial.com ) in early 2010 to evaluate the safety and effectiveness of ...
Related contentSunesis shares soar on leukemia drug trial results
18 hours ago ago from FanHouse
SOUTH SAN FRANCISCO, Calif. -Sunesis Pharmaceuticals Inc. said late Monday its drug candidate voreloxin improved survival for patients with treatment-resistant leukemia in clinical testing. The company's stock soared 17 cents, or 39 percent, to 61 cents ahead of Tuesday's market open. The stock has ranged from 5 cents to 90 cents over the past year. Late Monday, Sunesis reported results from two mid-stage trials of voreloxin as a treatment ...
Related content
